These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36161287)

  • 1. Clinical predictors of survival in real world practice in stage IV melanoma.
    Hu HP; Archer C; Yip D; Peters G
    Cancer Rep (Hoboken); 2023 Feb; 6(2):e1691. PubMed ID: 36161287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
    Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
    JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
    Gershenwald JE; Scolyer RA; Hess KR; Sondak VK; Long GV; Ross MI; Lazar AJ; Faries MB; Kirkwood JM; McArthur GA; Haydu LE; Eggermont AMM; Flaherty KT; Balch CM; Thompson JF;
    CA Cancer J Clin; 2017 Nov; 67(6):472-492. PubMed ID: 29028110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-institution validation of the AJCC staging system for stage IV melanoma.
    Neuman HB; Patel A; Ishill N; Hanlon C; Brady MS; Halpern AC; Houghton A; Coit DG
    Ann Surg Oncol; 2008 Jul; 15(7):2034-41. PubMed ID: 18465172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program.
    Tjokrowidjaja A; Browne L; Soudy H
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e280-e288. PubMed ID: 34811927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
    Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
    BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American Joint Committee on Cancer (AJCC8) staging.
    Conway AM; Salih Z; Papaxoinis G; Fletcher K; Weaver J; Patrao A; Noble R; Stamatopoulou S; Owen-Holt V; Mansoor W
    Med Oncol; 2017 Jun; 34(6):116. PubMed ID: 28500616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
    Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
    Zhou B; Xu L; Ye J; Xin L; Duan X; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4615-4621. PubMed ID: 28739761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase.
    Deichmann M; Kahle B; Moser K; Wacker J; Wüst K
    Br J Cancer; 2004 Aug; 91(4):699-702. PubMed ID: 15280926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
    Janka EA; Ványai B; Szabó IL; Toka-Farkas T; Várvölgyi T; Kapitány A; Szegedi A; Emri G
    Front Oncol; 2023; 13():1237643. PubMed ID: 37664072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need to restage Korean melanoma patients following publication of the 8th edition of the American Joint Committee on Cancer staging manual.
    Lee HJ; Park KD; Jang YH; Lee WJ; Lee SJ; Kim JY
    Indian J Dermatol Venereol Leprol; 2022; 88(3):332-336. PubMed ID: 34491680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study.
    Barreiro-Capurro A; Andrés-Lencina JJ; Podlipnik S; Carrera C; Requena C; Manrique-Silva E; Quaglino P; Tonella L; Jaka A; Richarz N; Rodríguez-Peralto JL; Ortiz P; Boada A; Ribero S; Nagore E; Malvehy J; Puig S
    Eur J Cancer; 2021 Mar; 145():29-37. PubMed ID: 33418234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.
    Doerler M; Hyun J; Venten I; Potthoff A; Bartke U; Serova K; Hoextermann S; Altmeyer P; Brockmeyer NH
    Eur J Med Res; 2007 Oct; 12(10):497-502. PubMed ID: 18024256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
    Lombardi A; Vitale V; Nigri G; Olivieri C; Mastrangeli MR; Bizzaglia E; Amanti C
    Breast J; 2020 Jul; 26(7):1265-1269. PubMed ID: 32180300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 45-year experience of uveal melanoma in Taiwan: Verification of American Joint Committee on Cancer staging system and prognostic factors.
    Ma ST; Hsieh YT; Wei YH; Liao SL
    J Formos Med Assoc; 2021 Jun; 120(6):1361-1368. PubMed ID: 33127270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Predictors of Response to Anti-PD-1 First-Line Treatment in a Single-Centre Patient Cohort: A Real-World Study.
    Di Pietro FR; Verkhovskaia S; Mastroeni S; Carbone ML; Abeni D; Di Rocco CZ; Samà N; Zappalà AR; Marchetti P; De Galitiis F; Failla CM; Fortes C
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e18-e24. PubMed ID: 34563446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
    Jiang W; Zhao B; Li Y; Qi D; Wang D
    BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.